Background: Some of the risk factors for osteoporosis population include: chronic immobilisation, insufficient dietary supply of calcium and vitamin D, decreased physical activity and long-term pharmacological treatment (glucocorticoids, anticonvulsant drugs). In disabled children and adolescents, the negative impact of these factors may cumulate to considerably impair the quality of life. Objectives: The aim of our study was to assess the vitamin D status and bone mineral density in children with chronic neurological syndromes. Material and Methods: A total of 34 children between 3 and 18 years of age were examined: 9 children with muscular dystrophy, 17 with cerebral palsy and 8 with lumbar myelomeningocele. All the subjects underwent the following assessments: measurement of the concentration of the hepatic metabolite of vitamin D and total body less head and/or lumbar spine densitometry by dual energy X-ray absorptiometry (DEXA). Low bone mass or low bone mineral density was diagnosed if the Z-score value was found to be equal to or below −2.0. Results: Indications for the above tests were chronic immobilisation or motor activity restriction, and-in 10/34 children-femoral or vertebral fracture. Vitamin D deficiency (<30 ng/ml) was detected in 27/33 patients (>81%). Low bone mass on densitometry was demonstrated in 27/34 and osteoporosis in 10/34 subjects (Z-score ≤ −2.0). Conclusion: Bone densitometry should be included in the standard of care for children with chronic neurological syndromes, and early detection of low bone mass should be an indication for treatment with calcium and vitamin D.
Introduction
Neuromuscular and neurodevelopmental disorders in children interfere with the normal physical activity and nutrition, and rendering it is completely impossible; the progressive nature of these disorders may lead to low bone mass and/or osteoporosis [1] [2] . The group at a particularly high risk of bone mineral loss includes children with cerebral palsy and muscular dystrophy and patients with motor activity restrictions secondary to permanent or progressive destruction of the locomotor system [3] . In all the paediatric chronic diseases which may affect the skeletal system, densitometric assessment of the bone is indicated [1] . This also applies to diseases which lead to motor disability. The diagnosis of low bone mineral density may also indicate an increased risk of clinically significant bone fracture and the need for treatment with vitamin D and calcium supplements and even with bisphosphonates [4] [5] .
The aim of our study was to assess bone mineral status and vitamin D status in disabled children and adolescents with cerebral palsy, muscular dystrophy, and with myelomeningocele.
Material and Methods
The observations cover the period 2005-2015 and concern 34 children between 3 and 18 years of age. A total of 9 children were diagnosed with muscular dystrophy and 17 with cerebral palsy. A total of 8/34 children had undergone neurosurgery as infants for lumbar myelomeningocele with ventriculoperitoneal shunt implantation for hydrocephalus accompanying the myelomeningocele. The children were referred to the Department of Paediatric Propaedeutics and Bone Metabolic Diseases from specialist outpatient clinics for evaluation of bone mineral metabolism.
The inclusion criteria involve: chronic diseases like muscular dystrophy or cerebral palsy or myelomeningocele, age 3 to 18 years old, skeletal system complaints (bone pains and/or fracture), lack of vitamin D supplementation 3 months before our study. The exclusion criteria contain: total parenteral nutrition in patient's medical history and endocrinological disorders.
Anthropometric measurements of weight and height were performed in each subject according to the generally accepted methodologies and the results were plotted on growth charts [6] . Measurements of basic parameters of calcium and phosphate metabolism, including serum concentration of the hepatic metabolite of vitamin D (i.e. 25-hydroxy vitamin D [25OHD]) by Elisa method, were performed in each subject [7] . In line with the guidelines developed for the Polish population of children, vitamin D deficiency was diagnosed at values below 30 ng/ml [8] . PTH levels were also measured by chemiluminescent microparticle immunoassay (CMIA) method.
Each of the patients underwent total body less head (TBLH) and/or anteroposterior (AP) lumbar spine (L1-L4) dual energy X-ray absorptiometry (DEXA) using Lunar Prodigy Advance (GE Healthcare). The duration of the DEXA scan E. Jakubowska-Pietkiewicz et al. 
Results
Somatic growth assessment and the number of bone/vertebral fractures in the study subjects are given in Table 1 .
According to it, weight and height deficiencies were most commonly present in In total, vitamin D deficiency was demonstrated in 27 patients and in 5/34 the level was below 10 ng/ml. Results of the other tests of calcium and phosphate metabolism, including PTH concentration, were within the respective reference ranges. An exception was a boy with cerebral palsy, who was found to be profoundly hypocalcaemic (he required intravenous administration of calcium, although clinically he was asymptomatic).
Individual values of Z-score in the TBLH and/or lumbar spine DEXA scan in the study subjects are given in Tables 2-4. According to Table 2 , in children with muscular dystrophies, 6/9 children below 10 years of age were found to have bone mineral density with a Z-score of less than −2.0.
Another 13/17 patients with cerebral palsy (Table 3 ) also had Z-score values in the TBLH and/or lumbar spine DEXA scan of less than −2.0, although in 6 children the assessment was performed based on one programme only.
In Table 4 , individual results of densitometry in patients with a history of surgery for myelomeningocele are shown. In 7/8 children, the Z-score in lumbar spine DEXA was equal to or below −2.0. In 1 patient, a 3-year-old boy, the scan was taken in the Infant option and the BMD was 0.522 g/cm 2 .
Discussion
Bone densitometry is part of the complex assessment of bone status in children and adolescents at increased risk of bone fracture [1] [9] [10] . This is particularly the case in patients with chronic inflammatory diseases, nutrition disorders, patients on long-term treatment with glucocorticosteroids and with markedly reduced motor activity [1] [3] . In the presented group of children, an indication for performing densitometry was motor activity restriction resulting from the underlying condition: cerebral palsy, muscular dystrophy, a history of surgery for myelomeningocele. In some of these children, osteoporosis was diagnosed according to The In- to 15% [2] , which is difficult to demonstrate in our patients because we have not presented continuous observations in our paper. No bone fractures were reported in our children with muscular dystrophy, although 2/7 were found to have low bone mineral density (a Z-score of less than −2.0), while three of them, with Duchenne muscular dystrophy were receiving glucocorticosteroids.
Glucocorticosteroid treatment, in addition to low mobility, negatively impacts bone mass in patients with muscular dystrophy, as pointed out by Houston et al. and Söderpalm et al. [11] [12]. It should be noted, however, than our study We also evaluated in our study the patient's skeletal system condition after surgery for myelomeningocele. In this group of patients, low bone mass was ac- These drugs are mainly used in disabled patients undergoing glucocorticosteroid treatment who have suffered bone fractures [21] .
They have also been used by us in 10 disabled children and adolescents with secondary osteoporosis, which will be addressed in a future publication.
Conclusion
Bone densitometry should be included in the standard of care for children with chronic neurological syndromes, and early detection of low bone mass should be an indication for treatment with calcium and vitamin D.
